Article Correctness Is Author's Responsibility: Early benefit assessments: 220th dossier assessment completed by the turn of the year

(Institute for Quality and Efficiency in Health Care) A host of dossiers assessed by IQWiG to date have addressed oncology drugs. Despite their significance, other diseases, e.g. Alzheimer dementia, are underrepresented.